Visualizar Tese - Instituto de Biociências - Unesp

Cirilo, PDRREFERÊNCIAS209Baker ME. Evolution of 17 beta-hydroxysteroid dehydrogenases and their role in androgen,estrogen and retinoid action. Mol Cell Endocrinol, 171, 211-215, 2001.Barbieri RL and Andersen J. Uterine leiomyomas. The somatic mutation theory. Sem ReprodEndocrinol, 10, 301-309, 1992.Bayani J and Squire JA. Comparative genomic hybridization. Curr Protoc Cell Biol, Chapter 22, Unit22.6, 2005.Bayani J, Marrano P, Graham C. Genomic instability and copy-number heterogeneity of chromosome19q, including the kallikrein locus, in ovarian carcinomas. Mol Oncol, 5, 48-60, 2011.Behera MA, Feng L, Yonish B et al. Thrombospondin-1 and Thrombospondin-2 mRNA and TSP-1and TSP-2 protein expression in uterine fibroids and correlation to the genes COL1A1 andCOL3A1 and to the collagen cross-link ydroxyproline. Reprod Sci, 14, 63-76, 2007.Beheshti B, Park PC, Braude I et al. Microarray CGH. Methods Mol Biol, 204, 191-207, 2002.Beroukhim R, Getz G, Nghiemphu L et al. Assessing the significance of chromosomal aberrations incancer: methodology and application to glioma. PNAS, 104, 20007-20012, 2007.Bhide RS, Lombardo LJ, Hunt JT et al. The antiangiogenic activity in xenograft models of brivanib, adual inhibitor of vascular endothelial growth factor receptor-2 and fibroblast growth factorreceptor-1 kinases. Mol Cancer Ther, 9, 369-378, 2010.Bisognin A, Coppe A, Ferrari F et al. A-MADMAN: annotation-based microarray data meta-analysistool. BMC Bioinformatics, 10, 201, 2009.Bisso A, Collavin L, Del Sal G. p73 as a Pharmaceutical Target for Cancer Therapy Curr Pharm Des,Epub ahead of print, 2011.Bodner-Adler B, Bodner K, Czerwenka K et al. Expression of p16 protein in patients with uterinesmooth muscle tumors: an immunohistochemical analysis. Gynecol Oncol, 96, 62-66, 2005.Bonatz G, Frahm SO, Andreas S et al. Telomere shortening in uterine leiomyomas. Am J ObstetGynecol, 179, 591-596, 1998.Bonazzi VF, Irwin D, Hayward NK. Identification of candidate tumor suppressor genes inactivatedby promoter methylation in melanoma. Genes Chromosomes Cancer, 48, 10-21, 2009.Borsari R, Bozzini N, Junqueira CR, et al. Genic expression of the uterine leiomyoma inreproductive-aged women after treatment with goserelin. Fertil Steril, 94, 1072-1077, 2010.Boveri T. Zur Frage der Entstehung maligner Tumoren. (Fischer, Jena, G.D.R.), 1914.Bowden W, Skorupski J, Kovanci E et al. Detection of novel copy number variants in uterineleiomyomas using high-resolution SNP arrays. Mol Hum Reprod, 15, 563-568, 2009.Bozzini N, Rodrigues CJ, Petti DA et al. Effects of treatment with gonadotropin releasing hormoneagonist on the uterine leiomyomata structure. Acta Obstet Gynecol Scand, 82, 330-334, 2003.